SCHEMBL9911193

SCHEMBL9911193

CC[C@H]1OC(c2ccc[nH]2)[C@](C)(OCc2ccccc2)[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9911205 0.81 — —
SCHEMBL9911204 0.81 — —
SCHEMBL13695337 0.79 HTR1A (0.35) —
SCHEMBL12365513 0.79 HTR1A (0.35) —
SCHEMBL9911195 0.76 IDO1 (0.33) —
SCHEMBL13998794 0.75 BCHE (0.32) —
SCHEMBL11997771 0.74 ALDH1A1 (0.30) —
SCHEMBL9911210 0.72 — —
SCHEMBL9911192 0.72 — —
SCHEMBL264614 0.71 CTSL (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8242085-B2 Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer BIOCRYST PHARMACEUTICALS, INC. (US) 2012-08-14 — — US disclosed
US-20120142617-A1 ANTIVIRAL THERAPEUTIC AGENTS BIOCRYST PHARMACEUTICALS, INC. (US) 2012-06-07 — — US disclosed
US-20110002886-A1 TETRAHYDROFURO [3,4-D] DIOXOLANE COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS AND CANCER BIOCRYST PHARMACEUTICALS, INC. (US) 2011-01-06 — — US disclosed
Send feedback